This combination of images provided by Edwards Lifesciences shows the Sapien 3 heart valve expanded, left, and crimped for insertion. AP filepic
PETALING JAYA: Shares of medical cable company Supercomnet Technologies Bhd
(Scomnet) have been seeing some interest following news that its largest client, California-based Edwards Lifesciences Corp, has received approval for its heart valve systems from the US Food and Drug Administration (FDA) on Aug 16.
Edwards Lifesciences’ share price hit a record high of US$223.95 on Aug 19.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
